MENU
OTLK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Outlook Therapeutics (OTLK) Earnings Date & Reports
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
OTLK is expected to report earnings to fall 60.00% to -5 cents per share on December 18
Q3'26
Est.
$-0.06
Q2'26
Beat
by $0.11
Q1'26
Beat
by $0.27
Q4'25
Missed
by $0.32
Q3'25
Missed
by $0.22
The last earnings report on August 14 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 1.90M shares outstanding, the current market capitalization sits at 128.98M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a manufacturer of biosimilar versions of biopharmaceuticals
Industry Biotechnology
Industry
Biotechnology
Address
111 S. Wood Avenue
Phone
+1 609 619-3990
Employees
17
Web
https://www.outlooktherapeutics.com